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In 2003, the World Health Assembly
endorsed a resolution to reduce measles
deaths by 50% compared with 1999
estimates by the end of 2005 [1]. This
target was met [2,3], and a new goal was
established to achieve 90% death reduc-
tion by 2010, compared with mortality in
2000 [4,5]. This new objective has not
been reached [6], jeopardizing the World
Health Organization (WHO) goal of
measles elimination in the WHO African
region by 2020 [7]. An elimination goal
has been pursued by some countries in
southern Africa since 1996 [8]. Despite
undeniable achievements, a recent resur-
gence of measles highlights the challenge
of sustaining elimination goals and the
uneven progress across sub-Saharan
Africa [9,10]. In 2010–2011, several sub-
Saharan African countries experienced
measles outbreaks, with more than
199,000 cases officially reported to WHO
in 2010, and more than 194,000 in 2011
[11]. These recent, large measles epidem-
ics in Africa, especially in countries with a
history of successful measles control, are of
great concern [12].
Current Practice for Measles
Outbreak Response
WHO guidelines for outbreak response
immunization (ORI) recommend consid-
ering measles control goals, background
vaccination coverage, age distribution of
cases, and case fatality rates when plan-
ning measles vaccination. Results from the
outbreak investigation and prior surveil-
lance data should be used to develop and
tailor an appropriate response. When
preliminary investigation indicates a high
risk of a large outbreak, a non-selective
mass vaccination campaign should be
implemented, and all age groups contrib-
uting to cases should be targeted, to avert
the largest number of cases and to
decrease transmission [13]. Unfortunately,
in the field, these guidelines are seldom
applied or are poorly implemented. In
common practice, at best, measles vacci-
nation interventions follow the Sphere
Project recommendation for humanitarian
emergencies: vaccinating against measles
in all children between the ages 6 months
and ,15 years old [14]. The same target
age range is generally recommended for
outbreak response interventions in order
to optimize impact [15]. However, differ-
ences in measles epidemiology and control
goals necessitate more than a one-size–fits-
all strategy. The public health objectives of
a measles outbreak response are context-
specific, depending essentially upon rou-
tine vaccination and the performance of
supplementary immunization activities
(SIAs). The age distribution of measles
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Summary Points
N During the recent resurgence of measles in sub-Saharan Africa, the majority of
cases were reported from the Democratic Republic of the Congo and Malawi,
two countries with vastly different measles epidemiology.
N Non-selective mass vaccination campaigns targeting children aged 6 months to
,15 years old are the commonly implemented strategy for responding to
measles outbreaks in humanitarian emergencies.
N Differences in measles epidemiology and country-specific control goals
necessitate more than a one-size-fits-all strategy.
N Measles outbreak responses should be tailored to local measles epidemiology
following early assessment: the age distribution of early cases should guide the
decision on which age groups to vaccinate.
N In settings where the main objective is mortality reduction, the youngest
children—who account for the most deaths and complications—should be
prioritized by the outbreak response.
PLOS Medicine | www.plosmedicine.org 1 November 2013 | Volume 10 | Issue 11 | e1001544
cases varies across sub-Saharan African
countries, reflecting different levels of
preexisting population immunity. This
variation is a consequence of past and
ongoing control programs and the degree
of circulating virus [16]. Whether the goal
in the country is mortality reduction or
measles elimination is a critical element to
be considered when planning and imple-
menting ORI.
Two Measles Epidemics with
Different Epidemiological
Profiles
During the measles resurgence in 2010–
2011, the majority of cases in the African
region were reported from the Democratic
Republic of the Congo (DRC) and Malawi,
two countries with vastly different measles
epidemiology. Non-selective mass vaccina-
tion campaigns targeting children aged 6
months to,15 years old were a part of the
Me´decins Sans Frontie`res (MSF) outbreak
response strategy in response to these
epidemics. In both countries, as part of
the support to the countries’ ministries of
health, MSF strengthened the surveillance
system in health zones or districts where
ORI was implemented. This process in-
cluded reinforcement of health officer
training in case definition and data collec-
tion, retrospective review of health regis-
ters, weekly communication of data to the
district level, monitoring of data complete-
ness, and electronic data compilation. In
both countries, national-level surveillance is
based on the Integrated Disease Surveil-
lance and Response strategy, and WHO
definitions for measles cases and deaths are
used. Once the outbreak is laboratory-
confirmed, additional cases are confirmed
clinically [13]. Therefore, it is possible that
some of the measles cases are misclassified
as rubella.
Here, we provide an overview of the
different epidemiology of these two epi-
demics in terms of the age distribution of
cases and discuss the need to reinforce
context-specific strategies. In DRC, be-
tween week 23 of 2010 and week 52 of
2011, 128,113 measles cases and 1,454
deaths were reported, with the bulk of
reported cases (60%) from Katanga Prov-
ince. In Katanga, the overall cumulative
attack rate (AR) was 0.71%, and the case
fatality ratio (CFR) was 1.40%. In Malawi,
between week 1 of 2010 and week 52 of
2010, 134,039 measles cases and 304
deaths were reported, with a cumulative
AR of 0.96% and a CFR of 0.23%.
The epidemiological profiles of these
two epidemics are distinguishable by the
age distribution of cases. In Katanga, the
median age of cases was 2 years (inter-
quartile range: 1–4), with 80% of reported
cases in children ,5 years old and only
6% in individuals $10 years old. In
Malawi, the median age of cases was 7
years (interquartile range: 1–16), with 41%
of reported cases in children ,5 years old
and 28% in individuals $15 years old
(Table 1). In both countries, almost a fifth
of cases were in children ,1 years old—
including children in the Expanded Pro-
gramme on Immunization target group
and younger—with ARs around 5%. In
Katanga, young children (12–59 months
old) were also highly affected, with AR
sharply decreasing in older children. In
Malawi, the AR was lower for young
children than for children of the same age
in Katanga, but much higher for age
groups .5 years old, as shown by the
incidence risk ratio (Figure 1).
Outbreak Response in Katanga,
a Post-Conflict Setting
In post-conflict countries, with long-
term disruption of immunization pro-
grams and poor access to health care,
measles is a major cause of child mortality
and further exacerbates subjacent malnu-
trition. In such contexts, the identification
of groups at higher risk of dying from
measles is essential to guide resource
allocation for outbreak response. In
DRC, measles transmission is high, epi-
demics are recurrent, and, typically, young
children are by far the most affected.
Previous studies highlight that measles
CFR is higher in unvaccinated children
,5 years old than in older children, with a
decreasing trend with each year increase
in age [17]. Unacceptably high measles-
related mortality has been documented in
children, particularly in countries in sub-
Saharan Africa that have failed to imple-
ment the WHO-recommended strategy
for sustainable measles mortality reduc-
tion. In such contexts, age-specific measles
CFRs show that infants and children ,3
years old are at highest risk of death [18].
The main objective of ORI in these
settings should be mortality reduction.
Deaths and measles complications can be
reduced by ensuring appropriate free
treatment of cases and protection through
immunization. When resources are limited
(insufficient vaccine supplies, lack of
trained staff, limited logistical capacity)
and the timely access to large affected
populations is needed, younger age groups
should be considered a priority and should
be vaccinated as soon as possible, with the
objective of reducing severe complications
and mortality [15].
During the outbreak in Katanga, MSF
vaccinated over 2.1 million individuals
aged 6 months to ,15 years in 26 health
zones. In the Haut-Lomami district of
Katanga, the target age group was re-
stricted to children aged 6 months to ,10
years, with 252,559 individuals vaccinated
in four health zones [19]. The decision to
limit the target age group was based on the
age distribution of early cases, showing low
AR among individuals $10 years old, to
optimize the use of available resources.
Although not the strategy implemented, a
more efficient use of limited resources and
a greater coverage of young children at
highest risk of death could have been
achieved by further limiting the target age
group.
Outbreak Response in Malawi, a
Stable Country
In stable countries with a measles
elimination goal, major outbreaks should
be avoided through a combination of good
routine coverage and consistent, high-
quality SIAs. Outbreaks in these settings
are the result of gaps in the routine
immunization program or failures of SIAs
to catch up non-immunized children.
When an outbreak is declared in such
contexts, all age groups contributing to
cases should be targeted during the
measles outbreak response, to avert the
largest number of cases and to decrease
transmission. This should be possible
where and if enough resources are allo-
cated to measles control.
Despite high reported measles vaccine
coverage and sustained low measles
transmission, in 2010 Malawi faced its
largest measles outbreak in more than
two decades. During the 2010 epidemic,
age groups $15 years contributed almost
one-third of the cases, as expected in a
setting with good, but not sustained,
vaccine coverage and effectiveness [10].
During the Malawi epidemic, MSF vac-
cinated through non-selective mass cam-
paigns over 3.3 million children aged 6
months to ,15 years, half of the
country’s total population for this age
group. However, outbreak response ef-
forts failed to control the epidemic
because vaccination campaigns were im-
plemented late in the course of the
epidemic, and transmission was sustained
by older individuals not targeted by the
ORI campaign. Targeting individuals
$15 years old would have had a greater
impact on the transmission dynamics
than did limiting vaccination to those
,15 years old. However, the financial,
human resource, and logistical costs of
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such interventions are substantial and
should be taken into account during
planning. Finally, the choice between
width of target age range and geograph-
ical coverage should always consider a
reasonable balance between feasibility,
cost, and expected impact.
The Need for a Context-Specific
Approach
In both settings, the highest ARs
occurred among infants 6–8 months old,
too young to be vaccinated by routine
programs. The benefit of vaccinating
earlier in regions with high birth rates, as
in Katanga, has been previously discussed
[20]. In Malawi, young infants aged 0–5
months were highly affected, with an AR
higher than that of children 12 months
and older. Recent studies showed lower
concentrations and earlier loss of maternal
antibodies against measles in infants of
vaccinated women than in infants of
naturally immune women [21]. In coun-
tries with effective measles vaccination
programs, maternal antibody levels against
measles may therefore be low. In such
contexts, early vaccination of infants
should be considered in the case of an
outbreak, as described elsewhere [22].
In both settings, ARs were higher for
young children born after the last SIA.
Among these children, the proportion
receiving their first or second dose during
the MSF reactive campaign was high,
suggesting that non-selective strategies
are efficient for poorly vaccinated age
groups or those that have not been
offered their second immunization op-
portunity. Nonetheless, the high propor-
tion of older individuals reporting having
received more than two doses suggests
that non-selective vaccination might not
be the most cost-effective option for
highly vaccinated populations. In such
contexts, cost–benefit studies are urgently
needed to evaluate the differential benefit
in terms of disease prevention and
mortality reduction [23] of continuing
with non-selective strategies to deliver the
second dose, whether in SIAs or ORI
campaigns.
As measles control improves across sub-
Saharan Africa, outbreak response vacci-
nation should also keep pace with these
improvements. Countries should set their
own priorities for outbreak response,
targeted to their measles control goals.
Immunization strategies should be tailored
to local measles epidemiology, following
early assessment. In particular, the age
distribution of early cases should guide the
decisions concerning which age groups to
target in priority. Measles vaccination is
an essential component of outbreak re-
sponse in settings where the main objective
is mortality reduction. In those contexts,
the youngest children—accounting for the
most deaths and complications—should be
prioritized.
Figure 1. Age distribution of measles cases in Katanga Province (Democratic Republic
of the Congo), 2010–2011, and in Malawi, 2010, as represented by attack rates, with
incidence risk ratio by age. The incidence risk ratio (irr) is the age-specific AR in Katanga
divided by the age-specific AR in Malawi.
doi:10.1371/journal.pmed.1001544.g001
Table 1. Measles cases, deaths, attack rates , and case fatality ratios by age group, reported in Malawi between week 1 and week
52 of 2010 and in Katanga Province between week 23 of 2010 and week 52 of 2011.
Age Group Malawi Katanga Province (DRC)
a
Number of
Cases (Percent)
AR per
100
Number of
Deaths (Percent)
CFR per
100
Number of
Cases (Percent)
AR per
100
Number of
Deaths (Percent)
CFR per
100
All 134,039 0.96 304 0.23 45,356 1.17 197 0.43
0–5 months 7,243 (5%) 2.26 10 (3%) 0.14 1,851 (4%) 2.31 7 (4%) 0.38
6–8 months 10,615 (8%) 7.61 27 (9%) 0.25 3,395 (7%) 8.49 22 (11%) 0.65
9–11 months 7,543 (6%) 4.50 21 (7%) 0.28 2,962 (7%) 7.40 19 (10%) 0.64
12–59 months 28,737 (22%) 1.38 81 (28%) 0.28 28,098 (62%) 4.68 126 (64%) 0.45
5–9 years 20,434 (16%) 1.05 44 (15%) 0.21 6,228 (14%) 0.97 17 (9%) 0.27
10–14 years 19,545 (15%) 1.00 25 (9%) 0.13 1,293 (3%) 0.23 3 (2%) 0.23
15–19 years 13,641 (10%) 1.00 14 (5%) 0.10 287 (1%) 0.08 0 0
$20 years 23,965 (18%) 0.40 70 (24%) 0.29 847 (2%) 0.05 2 (1%) 0.24
Percent values in parentheses are percent of all cases or deaths that are in that age group. Population figures for Malawi are a projection from estimates of the 2008
Population and Housing Census [24]; population figures for Katanga are a projection from estimates of the 2007 Demographic and Health Survey [25].
aData are from only the 28 health zones of Katanga where surveillance was reinforced.
doi:10.1371/journal.pmed.1001544.t001
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